De volta aos polimorfismos genéticos do EGF+61 e risco de câncer do pulmão
olhando para o futuro!
Downloads
Referências
Hu-Lieskovan S, Vallbohmer D, Zhang W, et al. EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients. Clin Cancer Res. 2011;17(15):5161-9.
Lim YJ, Kim JW, Song JY, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett. 2005;374(3):157-60.
Kang HG, Choi JE, Lee WK, et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology. 2007;12(6):902-5.
de Mello RA, Ferreira M, Costa BM, et al. Association between +61 A/G polymorphism in the EGF gene and non-small cell lung cancer risk in male caucasians. Eur J Cancer. 2011;47(Suppl 1):S635. [poster 9139].
Zhang YM, Cao C, Liang K. Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epidemiol. 2010;34(2):150-6.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.